Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says

Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says


Weight-loss drugs have become a hot topic as public heath authorities and pharmaceutical companies seek to find solutions to the growing global obesity epidemic.

Florian Gaertner | Photothek | Getty Images

An oral drug made by Pfizer causes a similar amount of weight loss as, and works quicker than, rival Novo Nordisk‘s blockbuster injection Ozempic, according to results from a phase two clinical trial released Monday.

The results were presented at a medical conference late last year. But JAMA Network only now is releasing the full peer-reviewed study.

Pfizer’s trial followed 411 adults with Type 2 diabetes who either took the company’s pill, danuglipron, twice a day or a placebo. 

Patients who took a 120-milligram version of danuglipron lost around 10 pounds over the course of 16 weeks, the study found.

That compares with a phase three clinical trial on Ozempic, which found that adults who took a 1-milligram version of the injection lost around 9.9 pounds on average over 30 weeks. Patients take that shot once a week. 

The results suggest danuglipron may be as effective for weight as Ozempic over a shorter period of time. 

Pfizer’s drug also could offer an advantage as an oral treatment option rather than a frequent injection.

Both danuglipron and Ozempic are part of a class of drugs called glucagon-like peptide-1 antagonists.

They mimic a hormone produced in the gut called GLP-1, which signals to the brain when a person is full. 

The drugs can also help people manage Type 2 diabetes because they encourage insulin release from the pancreas, lowering blood sugar levels.

New York-based Pfizer is the latest pharmaceutical company to dip into the blockbuster weight loss drug market. 

Novo Nordisk’s Ozempic and Wegovy catapulted to the national spotlight in recent years for being weight loss “miracles.”

Hollywood celebrities, social media influencers, and billionaire tech mogul Elon Musk have reportedly used the popular injections to get rid of unwanted weight. 

But experts say the medicines may further perpetuate a dangerous diet culture that idealizes weight loss and thinness.

Some patients who stop taking the drugs also complain about a weight rebound that is difficult to control.

More than 2 in 5 adults have obesity, according to the National Institutes of Health. About 1 in 11 adults have severe obesity.



Source

Starbucks is about to report earnings. Here’s what to expect
Business

Starbucks is about to report earnings. Here’s what to expect

Consumers walk in front of a Starbucks coffee shop in Galeria Krakowska shopping mall in central Krakow, Poland, on July 11, 2025. Dominika Zarzycka | Nurphoto | Getty Images Starbucks is expected to report its fiscal third-quarter earnings after the bell on Tuesday. Here’s what Wall Street analysts surveyed by LSEG are expecting the company […]

Read More
Nike loses head of North America women’s business to Athleta
Business

Nike loses head of North America women’s business to Athleta

A Nike and Athleta store. Kylie Cooper | Reuters | Michael Brochstein | SOPA Images | LightRocket | Getty Images Gap’s Athleta has tapped the head of Nike’s women’s business in North America as its next CEO, delivering a blow to the sneaker company as it tries to win back more female shoppers.  Maggie Gauger, […]

Read More
NFL employee seriously injured in shooting at NYC headquarters
Business

NFL employee seriously injured in shooting at NYC headquarters

NFL Commissioner Roger Goodell told employees in an email early Tuesday morning that one of the league’s employees was seriously injured in a Monday shooting at a Midtown Manhattan office tower. “A gunman committed an unspeakable act of violence in our building at 345 Park Avenue,” Goodell said. “The employee is in stable condition and […]

Read More